Evaluate the Safety and Efficacy of 'BRFS-18G-S100WH' as Compared to 'MINT Lift FINE+' in Subject With Nasolabial Folds

Launched by HUGEL · Jan 19, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new treatment called 'BRFS-18G-S100WH' to see how safe and effective it is compared to another treatment known as 'MINT Lift FINE+' for reducing nasolabial folds, which are the lines that run from the sides of your nose to the corners of your mouth. The trial is currently recruiting participants who are adults over 19 years old and have moderate to severe nasolabial folds. If you or someone you know is interested in improving these lines on the face and meets the criteria, you may be eligible to participate.

Participants in this trial can expect to receive one of the two treatments and will be monitored for their safety and results. It's important to note that individuals who have recently had fillers or certain facial procedures, as well as pregnant or breastfeeding women, cannot join the study. By taking part in this trial, you could help researchers learn more about these treatments while potentially benefiting from a temporary improvement in the appearance of nasolabial folds.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Adults over 19 years of age
• • 2. Those who wish to temporarily improve nasolabial folds on both sides of the face and have a score of 3 (Moderate) or 4 (Severe) on the WSRS (Wrinkle Severity Rating Scale)
• • 3. Those who voluntarily decided to participate in this clinical trial and agreed to the subject description and consent form in writing
• Exclusion Criteria:
• • 1. A person who has undergone a procedure using filler or facial tissue fixation thread on the facial area.
• • 2. Those who are pregnant or lactating